The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Cardiogenic Shock

Steven M. Hollenberg, MD; Clifford J. Kavinsky, MD, PhD; and Joseph E. Parrillo, MD
[+] Article, Author, and Disclosure Information

From Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.

Requests for Reprints: Steven M. Hollenberg, MD, Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Suite 1159, Chicago, IL 60612.

Current Author Addresses: Dr. Hollenberg: Sections of Cardiology and Critical Care Medicine, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Suite 1159, Chicago, IL 60612.

Drs. Kavinsky and Parrillo: Section of Cardiology, Rush-Presbyterian-St. Luke's Medical Center, 1653 West Harrison Street, Chicago, IL 60612.

Ann Intern Med. 1999;131(1):47-59. doi:10.7326/0003-4819-131-1-199907060-00010
Text Size: A A A

Purpose: To review the cause, epidemiology, pathophysiology, and treatment of cardiogenic shock.

Data Sources: A MEDLINE search of the English-language reports published between 1976 and 1998 and a manual search of bibliographies of relevant papers.

Study Selection: Experimental, clinical, and basic research studies related to cardiogenic shock.

Data Extraction: Data in selected articles were reviewed, and relevant clinical information was extracted.

Data Synthesis: Cardiogenic shock is a state of inadequate tissue perfusion due to cardiac dysfunction, most commonly caused by acute myocardial infarction. Mortality rates for patients with cardiogenic shock remain frustratingly high, ranging from 50% to 80%. The pathophysiology of cardiogenic shock involves a downward spiral: Ischemia causes myocardial dysfunction, which, in turn, worsens ischemia. Areas of nonfunctional but viable (stunned or hibernating) myocardium can also contribute to the development of cardiogenic shock. The key to achieving a good outcome is an organized approach that includes rapid diagnosis and prompt initiation of therapy to maintain blood pressure and cardiac output. Expeditious coronary revascularization is crucial. When available, emergency cardiac catheterization and angioplasty seem to improve survival. More recent developments, such as placement of coronary stents and use of glycoprotein IIb/IIIa antagonists, are promising but have not yet been well studied in patients with cardiogenic shock. In hospitals without direct angioplasty capability, stabilization with intra-aortic balloon counterpulsation and thrombolysis followed by transfer to a tertiary care facility may be the best option.

Conclusions: Improved understanding of the pathophysiology of shock and myocardial infarction has led to improved treatment. If cardiogenic shock is managed with rapid evaluation and prompt initiation of supportive measures and definitive therapy, outcomes can be improved.


Grahic Jump Location
Figure 1.
The downward spiral in cardiogenic shock.

LVEDP = left ventricular end-diastolic pressure.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Potential consequences of myocardial ischemia.
Grahic Jump Location
Grahic Jump Location
Figure 3.
An approach to the diagnosis and treatment of cardiogenic shock caused by myocardial infarction.

CABG = coronary artery bypass grafting; IABP = intra-aortic balloon pumping.

Grahic Jump Location




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.